Though our finding is contrary to what is found in most studies on EGFR-mutated lung cancer, it is similar to a study on 310 lung cancer patients, which noted a protective effect of EGFR-mutated patients on DVT risk [45]. The gene discussed is EGFR; the disease is lung cancer.